This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Novocure Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Kirill Stepovoy: Innovator in Tumor Treating Fields Technology
Introduction
Kirill Stepovoy is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of medical technology, particularly in the area of tumor treatment. His innovative approach focuses on the application of alternating electric fields to enhance therapeutic outcomes for patients.
Latest Patents
Kirill Stepovoy holds a patent for a groundbreaking method titled "Selecting values of parameters for treatment using tumor treating fields (TTFields)." This patent describes a system that selects characteristics of alternating electric fields to be applied to a target region in a subject's body. By applying different sets of pulses between electrode elements positioned on opposite sides of the target region, the system determines thermal responses to these pulses. Based on the thermal responses, it selects a set of characteristics for output pulses of alternating current that aim to maximize peak current amplitude while keeping temperatures at the electrode elements below a threshold value. He has 1 patent to his name.
Career Highlights
Kirill Stepovoy is associated with Novocure GmbH, a company that specializes in innovative cancer treatment technologies. His work at Novocure has been instrumental in advancing the understanding and application of tumor treating fields in clinical settings.
Collaborations
Throughout his career, Kirill has collaborated with esteemed colleagues, including Moshe Giladi and Reuven Ruby Shamir. These collaborations have further enriched his research and development efforts in the field of medical technology.
Conclusion
Kirill Stepovoy's contributions to the field of tumor treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work continues to influence the landscape of medical technology and cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
